We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

10 hedge funds and large institutions have $41M invested in Altamira Therapeutics Ltd in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 11 → 10 (-1)

32% less capital invested

Capital invested by funds: $60.6M → $41M (-$19.7M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$383K
2
HCM
Harvey Capital Management
Florida
+$383K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$2.3M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$1.11M
3
CPCM
Clifton Park Capital Management
Delaware
-$383K
4
WA
Wasatch Advisors
Utah
-$383K
5
SFM
Sphera Funds Management
Israel
-$316K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$9.41M -$383K -1 -3%
BAMS
2
Bellevue Asset Management (Switzerland)
Switzerland
$7.72M – – –
TCM
3
Tekla Capital Management
Massachusetts
$7.5M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.93M – – –
CPCM
5
Clifton Park Capital Management
Delaware
$5.53M -$383K -1 -5%
RCM
6
RA Capital Management
Massachusetts
$1.67M -$2.3M -6 -50%
OM
7
Opaleye Management
Massachusetts
$1.26M – – –
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$1.02M +$383K +1 +33%
TAM
9
Tocqueville Asset Management
New York
$356K – – –
HCM
10
Harvey Capital Management
Florida
$241K +$383K +1 New
KeyBank National Association
11
KeyBank National Association
Ohio
$110K – – –
Goldman Sachs
12
Goldman Sachs
New York
$60K – – –
Morgan Stanley
13
Morgan Stanley
New York
$43K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$43K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$31K – – –
UBS Group
16
UBS Group
Switzerland
$21K – – –
Walleye Trading
17
Walleye Trading
New York
$1K – – –
Wells Fargo
18
Wells Fargo
California
$1K – – –
SAM
19
Sectoral Asset Management
Quebec, Canada
– -$1.11M -3 Closed
SFM
20
Sphera Funds Management
Israel
– -$316K -1 Closed
Bank of America
21
Bank of America
North Carolina
– -$4K – –
OA
22
Omega Advisors
New York
– -$174K – –
RFC
23
Russell Frank Company
Washington
– -$2K – –

CYTO Hedge Fund Activity: Q3 2015 in Review

10 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2015, worth a combined $41M — down 32% from $60.6M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CYTO and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Alyeska Investment Group, adding an estimated $383K. The largest seller was RA Capital Management, cutting an estimated $2.3M.

  • 10 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2015, down from 11 in Q2 2015.
  • Funds reported $41M of Altamira Therapeutics Ltd stock for Q3 2015, down 32% quarter-over-quarter.
  • 1 fund opened new Altamira Therapeutics Ltd positions in Q3 2015 and 2 closed out, a net change of -1 holder.
  • The largest Altamira Therapeutics Ltd buyer in Q3 2015 was Alyeska Investment Group, an estimated $383K added.
  • The largest Altamira Therapeutics Ltd seller in Q3 2015 was RA Capital Management, an estimated $2.3M sold.

Based on aggregated 13F filings for Q3 2015.